Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
mq719
Sebaceous Adenocarcinoma
Memorial Sloan Kettering Cancer CenterP1CC (43)
Mrna-4203
Synovial Sarcoma
Immatics US, Inc.P1CC (43)
Mrna Hbv/Tcr T-Cells
Hepatocellular Carcinoma
Lion TCR Pte. Ltd.P1CC (43)
Mrtx0902
Colorectal Cancer
Mirati Therapeutics Inc.P1CC (43)
Mrtx1133
Cancer
Mirati Therapeutics Inc.P1CC (43)
Mrtx1133
Colorectal Cancer
Mirati Therapeutics Inc.P1CC (43)
Mrtx1133
Non-Small Cell Lung Carcinoma
Mirati Therapeutics Inc.P1CC (43)
Mrtx1133
Pancreatic Adenocarcinoma
Mirati Therapeutics Inc.P1CC (43)
Mrtx1133
Neoplasm
Mirati Therapeutics Inc.P1CC (43)
Mrtx1719
Malignant Peripheral Nerve Sheath Tumor
Bristol-Myers SquibbP1CC (43)
mrx0005
Parkinson Disease
4D pharma plcP1CC (43)
mrx0029
Parkinson Disease
4D pharma plcP1CC (43)
Mrx-2843
Non-Small Cell Lung Carcinoma
Emory UniversityP1CC (43)
Mst-0312
Neoplasm
Mestag Therapeutics LimitedP1CC (43)
mt027
Central Nervous System Neoplasm
Suzhou Maximum Bio-tech Co., Ltd.P1CC (43)
mt027
Brain Neoplasm
Suzhou Maximum Bio-tech Co., Ltd.P1CC (43)
mt027
Pleural Neoplasm
Suzhou Maximum Bio-tech Co., Ltd.P1CC (43)
mt027
Malignant Pleural Mesothelioma
Suzhou Maximum Bio-tech Co., Ltd.P1CC (43)
mt-302
Carcinoma
Myeloid TherapeuticsP1CC (43)
mt-401-ots
Acute Myeloid Leukemia
Marker Therapeutics, Inc.P1CC (43)
mts105
Liver Cancer
Shen LinP1CC (43)
Muamycin
Digestive System Cancer
National Cancer Institute (NCI)P1CC (43)
Muamycin
Uterine Cancer
City of Hope Medical CenterP1CC (43)
Muamycin
Gastric Carcinoma
City of Hope Medical CenterP1CC (43)
Muamycin
Ovarian Carcinoma
City of Hope Medical CenterP1CC (43)
Showing 3401 to 3425 of 9,920 assets
PreviousPage 137 of 397Next